SPIELBERG THEODORE E has a total of 12 patent applications. Its first patent ever was published in 1973. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets medical technology, pharmaceuticals and biotechnology are KCL LICENSING INC, KONVATEK TEKNOLODZHIZ INK and ERIKSSON ELOF.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Implantable devices | |
#2 | Medical preparations | |
#3 | Syringes | |
#4 | Object sterilising | |
#5 | Microorganisms | |
#6 | Unspecified technologies | |
#7 | Peptides | |
#8 | Physical therapy devices |
# | Name | Total Patents |
---|---|---|
#1 | Spielberg Theodore E | 12 |
#2 | Marshall Robert A | 1 |
Publication | Filing date | Title |
---|---|---|
US2008243235A1 | Cellular transplant stent | |
US7044965B1 | Therapeutic cellular stent | |
US7018419B2 | Microporous encapsulated endocrine cell disks, biconcave disks and multidimpled chambers for hormonal replacement | |
US6048306A | Non-invasive dual acting urological press for the prevention of female incontinence | |
WO9415466A1 | Surrogate endocrine glands by genetic reassignment | |
US4925555A | Ultrafiltering hybrid artificial organ | |
WO8401287A1 | Encapsulated genetically programmed living organisms producing therapeutic substances | |
CA1213404A | Ultrafiltering hybrid artificial organ | |
CA1027304A | Artificial gland structure | |
US3859989A | Therapeutic cuff |